MCD
42
-4
KO
42
-2
LNC
68
-2
PEG
46
-2
CCL
82
-4
KMI
63
-2
ADI
73
-3
GS
75
-3
ZBH
47
2
HAS
68
2
VRSK
35
3
OXY
38
-2
MAT
54
4
BAX
41
3
CF
36
-2
VZ
42
3
V
52
-2
URBN
51
-3
NRG
52
2
GWW
62
-3
MCD
42
-4
KO
42
-2
LNC
68
-2
PEG
46
-2
CCL
82
-4
KMI
63
-2
ADI
73
-3
GS
75
-3
ZBH
47
2
HAS
68
2
VRSK
35
3
OXY
38
-2
MAT
54
4
BAX
41
3
CF
36
-2
VZ
42
3
V
52
-2
URBN
51
-3
NRG
52
2
GWW
62
-3
Financhill
Back

Quince Therapeutics, Inc. 10K Form

Buy
53

QNCX
Quince Therapeutics, Inc.

Last Price:
$3.53
Seasonality Move:
-7.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive QNCX News And Ratings

See the #1 stock for the next 7 days that we like better than QNCX

QNCX Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-10M
Price / Cash Flow: 0
Annual Sales: $0.02
Price / Book: 187.22

Profitability

EPS (TTM): -1.21890
Net Income (TTM): $-57M
Gross Margin: $-186K
Return on Equity: -267.62%
Return on Assets: -48.55%

Quince Therapeutics, Inc. Earnings Forecast

Key Quince Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 8 years have been positive in 2 years.

Quince Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: QNCX
Website: quincetx.com

Debt

Debt-to-Equity Ratio: 16.99
Current Ratio: 1.12
Quick Ratio: 1.01

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

QNCX Technical Analysis vs Fundamental Analysis

Buy
53
Quince Therapeutics, Inc. (QNCX) is a Buy

Is Quince Therapeutics, Inc. a Buy or a Sell?